Abstract:Introduction & Objective: A common (~25%) splice variant rs72613567:TA in hydroxysteroid dehydrogenase 17-beta 13 (HSD17B13) was shown to reduce the risk of hepatic fibrosis and cirrhosis. The mechanism underlying the protective function remains unclear. Methods: Carriers (n=647 of 1353) of the splice variant in the cohort of the German Diabetes Study (GDS) were identified by reverse transcription-polymerase chain reaction. Phenotyping comprised hepatic lipid content (HLC) and liver energy metabolism (inorganic phosphate (Pi), γATP by 1H/31P-magnetic resonance spectroscopy), insulin secretion, hepatic and whole-body insulin sensitivity (Botnia clamps with [6,6-2H2]glucose), physical fitness (spiroergometry with lactate assessment), resting energy expenditure during fasting and clamp (indirect calorimetry) including up to 2331 measurements and covering repeated visits over 15 years. Results: Compared to non-carriers, carriers of the hepatoprotective minor allele showed similar hepatic insulin sensitivity and γATP, but higher HLC and Pi, lower alanine aminotransferase (ALT) levels and an attenuated lactate increase after reaching the anaerobic threshold (VO2AT) (pinteraction=2E-11). This genetic modification associates with post-exercise lactate rise and was driven by elevated fasting plasma glucose levels (pinteraction=5E-4). Fasting endogenous glucose production, insulinemia, glycemia, energy expenditure, insulin sensitivity (M-value) and secretion were similar between groups. Only female carriers showed lower physical fitness (VO2 peak and VO2AT). Conclusion: Higher hepatic Pi suggests alterations of hepatic energy metabolism in carriers of the hepatoprotective variant. The blunted increase in lactate post VO2AT, depending on fasting glucose levels, highlights a potential link between the HSD17B13 variant and altered lactate kinetics during anaerobic exercise in diabetes. Disclosure D.M. Mendez Cardenas: None. K. Bódis: None. K. Prystupa: None. I. Yurchenko: None. M. Schön: None. C. Möser: None. O.P. Zaharia: None. D. Pesta: None. M. Heni: Research Support; Boehringer-Ingelheim. Advisory Panel; Amryt Pharma Plc. Speaker's Bureau; Amryt Pharma Plc. Advisory Panel; Boehringer-Ingelheim, Boehringer-Ingelheim. Speaker's Bureau; Lilly Diabetes, Novartis AG, Novo Nordisk, Sanofi. K. Pafili: None. Y. Kupriyanova: None. V. Schrauwen-Hinderling: None. M. Roden: Advisory Panel; Eli Lilly and Company. Research Support; Boehringer-Ingelheim. Advisory Panel; Novo Nordisk. Research Support; Novo Nordisk. Advisory Panel; TARGET PharmaSolutions, Inc. Speaker's Bureau; AstraZeneca. B. Knebel: None. R. Wagner: Speaker's Bureau; Sanofi. Advisory Panel; Lilly Diabetes. Speaker's Bureau; Boehringer-Ingelheim, Novo Nordisk. H. Al-Hasani: None. M. Bombrich: None.

The polymorphism T1470A of the SLC16A1 gene is associated with the lactate and ventilatory thresholds but not with fat oxidation capacity in young men

T-Allele Carriers of Mono Carboxylate Transporter One Gene Polymorphism rs1049434 Demonstrate Altered Substrate Metabolization during Exhaustive Exercise

The MCT1 gene Glu490Asp polymorphism (rs1049434) is associated with endurance athlete status, lower blood lactate accumulation and higher maximum oxygen uptake

ACSL5 genotype influence on fatty acid metabolism: a cellular, tissue, and whole-body study

ACYL-CoA synthetase long-chain 5 polymorphism is associated with weight loss and metabolic changes in response to a partial meal-replacement hypocaloric diet

Impact of LPL gene rs283 polymorphism on exercise-induced changes in metabolism of obese adolescents and the regulatory mechanisms behind it

Biomarkers and genetic polymorphisms associated with maximal fat oxidation during physical exercise: implications for metabolic health and sports performance

Genetic Polymorphisms in SOD (rs2070424, rs7880) and CAT (rs7943316, rs1001179) Enzymes Are Associated with Increased Body Fat Percentage and Visceral Fat in an Obese Population from Central Mexico

Changes in lactate concentration are accompanied by opposite changes in the pattern of fat oxidation: Dose–response relationship

The A98V Single Nucleotide Polymorphism (SNP) in Hepatic Nuclear Factor 1 α (<i>HNF-1</i>α) is Associated with Insulin Sensitivity and β-Cell Function

A partial loss-of-function variant (Ile191Val) of the TAS1R2 glucose receptor is associated with enhanced responses to exercise training in older adults with obesity: A translational study

The Association of Genetic Markers Involved in Muscle Performance Responding to Lactate Levels during Physical Exercise Therapy by Nordic Walking in Patients with Long COVID Syndrome: A Nonrandomized Controlled Pilot Study

Variability in the Aerobic Fitness-Related Dependence on Respiratory Processes During Muscle Work Is Associated With the ACE-I/D Genotype

Effects of Four Lipid Metabolism-Related Polymorphisms on Body Composition Improvements After 12 Weeks of High-Intensity Interval Training and Dietary Energy Restriction in Overweight/Obese Adult Women: A Pilot Study

The Genetic Variability of Members of the SLC38 Family of Amino Acid Transporters (SLC38A3, SLC38A7 and SLC38A9) Affects Susceptibility to Type 2 Diabetes and Vascular Complications

12-Week aerobic exercise and nutritional program minimized the presence of the 64Arg allele on insulin resistance

508-P: The Metabolic Phenome of the Hepatoprotective HSD17B13 Splice Variant rs72613567:TA Suggests Higher Lactate Clearance

Common functional polymorphisms in SLC6A4 and COMT genes are associated with circadian phenotypes in a South American sample

Comprehensive Systematic Review and Meta-Analysis of Solute Carrier Family 19, Member 1 (SLC19A1) G80A Gene Polymorphism and Its Association with Congenital Heart Defects in Fetal Development: Implications for Genetic Susceptibility and Prenatal Risk Assessment

Anxiety-related Endophenotypes and Hazardous Alcohol Use in Young Adults are Associated with a Functional Polymorphism in the SLC6A4 Gene

rs1769793 variant reduces EGLN1 expression in skeletal muscle and hippocampus and contributes to high aerobic capacity in hypoxia